Skip to main content

Highlights

  1. 1
    Retina (Philadelphia, Pa.) · 2024
    PMID: 37651732DOISenior author11 citations

Publications

70 publications

Funding

2 grants

Active

1 grant
  • PI
    ROP3-ROP4 studies
    Jaeb Center for Health Research, Inc. · 2021–2025
    JCHR 214783-02
Completed grants (1)
  • Sub-PI
    Partnership for ROP Evaluation in the Real world (PROPER)
    Genentech, Inc. · 2019–2022 · via Oregon Health & Science University
    OHSU G-70996

Clinical research

2 studies
Completed & closed trials (2)
  • PI
    Partnership for ROP Evaluation in the Real world (PROPER)
    Oregon Health & Science University · IRB STUDY CLOSURE (as of 2022)
  • PI
    Randomized, Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
    PHASE3 · Regeneron Pharmaceuticals, Inc. · IRB STUDY CLOSURE (as of 2021)
    Retinopathy of Prematurity
    NCT04101721

External relationships

Other Interest

Apellis Pharmaceuticals, Inc. · Carl Zeiss · Genentech, Inc.